Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

Standard

Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. / Miura, Noriyoshi; Mori, Keiichiro; Laukhtina, Ekaterina; Schuettfort, Victor M; Abufaraj, Mohammad; Teoh, Jeremy Y C; Luzzago, Stefano; Stolzenbach, Franziska; Deuker, Marina; Karakiewicz, Pierre I; Briganti, Alberto; Enikeev, Dmitry V; Rouprêt, Morgan; Margulis, Vitaly; Chlosta, Piotr; Nyirady, Peter; Babjuk, Marek; Egawa, Shin; Saika, Takashi; Shariat, Shahrokh F.

in: JPN J CLIN ONCOL, Jahrgang 51, Nr. 7, 01.07.2021, S. 1149-1157.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Miura, N, Mori, K, Laukhtina, E, Schuettfort, VM, Abufaraj, M, Teoh, JYC, Luzzago, S, Stolzenbach, F, Deuker, M, Karakiewicz, PI, Briganti, A, Enikeev, DV, Rouprêt, M, Margulis, V, Chlosta, P, Nyirady, P, Babjuk, M, Egawa, S, Saika, T & Shariat, SF 2021, 'Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration', JPN J CLIN ONCOL, Jg. 51, Nr. 7, S. 1149-1157. https://doi.org/10.1093/jjco/hyab023

APA

Miura, N., Mori, K., Laukhtina, E., Schuettfort, V. M., Abufaraj, M., Teoh, J. Y. C., Luzzago, S., Stolzenbach, F., Deuker, M., Karakiewicz, P. I., Briganti, A., Enikeev, D. V., Rouprêt, M., Margulis, V., Chlosta, P., Nyirady, P., Babjuk, M., Egawa, S., Saika, T., & Shariat, S. F. (2021). Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. JPN J CLIN ONCOL, 51(7), 1149-1157. https://doi.org/10.1093/jjco/hyab023

Vancouver

Bibtex

@article{93099251f0cc4b2b8b7f80eb5352a1bf,
title = "Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration",
abstract = "OBJECTIVE: To assess the value of preoperative albumin to globulin ratio for predicting pathologic and oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy in a large multi-institutional cohort.MATERIALS AND METHODS: Preoperative albumin to globulin ratio was assessed in a multi-institutional cohort of 2492 patients. Logistic regression analyses were performed to assess the association of the albumin to globulin ratio with pathologic features. Cox proportional hazards regression models were performed for survival endpoints.RESULTS: The optimal cut-off value was determined to be 1.4 according to a receiver operating curve analysis. Lower albumin to globulin ratios were observed in 797 patients (33.6%) compared with other patients. In a preoperative model, low preoperative albumin to globulin ratio was independently associated with nonorgan-confined diseases (odds ratio 1.32, P = 0.002). Patients with low albumin to globulin ratios had worse recurrence-free survival (P < 0.001), cancer-specific survival (P = 0.001) and overall survival (P = 0.020) in univariable and multivariable analyses after adjusting for the effect of standard preoperative prognostic factors (recurrence-free survival: hazard ratio (HR) 1.31, P = 0.001; cancer-specific survival: HR 1.31, P = 0.002 and overall survival: HR 1.18, P = 0.024).CONCLUSIONS: Lower preoperative albumin to globulin ratio is associated with locally advanced disease and worse clinical outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. As it is difficult to stage disease entity, low preoperative serum albumin to globulin ratio may help identify those most likely to benefit from intensified care, such as perioperative systemic therapy, and the extent and type of surgery.",
keywords = "Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Nephroureterectomy, Preoperative Period, Prognosis, Proportional Hazards Models, Serum Albumin/analysis, Serum Globulins/analysis, Urinary Bladder Neoplasms/blood",
author = "Noriyoshi Miura and Keiichiro Mori and Ekaterina Laukhtina and Schuettfort, {Victor M} and Mohammad Abufaraj and Teoh, {Jeremy Y C} and Stefano Luzzago and Franziska Stolzenbach and Marina Deuker and Karakiewicz, {Pierre I} and Alberto Briganti and Enikeev, {Dmitry V} and Morgan Roupr{\^e}t and Vitaly Margulis and Piotr Chlosta and Peter Nyirady and Marek Babjuk and Shin Egawa and Takashi Saika and Shariat, {Shahrokh F}",
note = "{\textcopyright} The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.",
year = "2021",
month = jul,
day = "1",
doi = "10.1093/jjco/hyab023",
language = "English",
volume = "51",
pages = "1149--1157",
journal = "JPN J CLIN ONCOL",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

AU - Miura, Noriyoshi

AU - Mori, Keiichiro

AU - Laukhtina, Ekaterina

AU - Schuettfort, Victor M

AU - Abufaraj, Mohammad

AU - Teoh, Jeremy Y C

AU - Luzzago, Stefano

AU - Stolzenbach, Franziska

AU - Deuker, Marina

AU - Karakiewicz, Pierre I

AU - Briganti, Alberto

AU - Enikeev, Dmitry V

AU - Rouprêt, Morgan

AU - Margulis, Vitaly

AU - Chlosta, Piotr

AU - Nyirady, Peter

AU - Babjuk, Marek

AU - Egawa, Shin

AU - Saika, Takashi

AU - Shariat, Shahrokh F

N1 - © The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

PY - 2021/7/1

Y1 - 2021/7/1

N2 - OBJECTIVE: To assess the value of preoperative albumin to globulin ratio for predicting pathologic and oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy in a large multi-institutional cohort.MATERIALS AND METHODS: Preoperative albumin to globulin ratio was assessed in a multi-institutional cohort of 2492 patients. Logistic regression analyses were performed to assess the association of the albumin to globulin ratio with pathologic features. Cox proportional hazards regression models were performed for survival endpoints.RESULTS: The optimal cut-off value was determined to be 1.4 according to a receiver operating curve analysis. Lower albumin to globulin ratios were observed in 797 patients (33.6%) compared with other patients. In a preoperative model, low preoperative albumin to globulin ratio was independently associated with nonorgan-confined diseases (odds ratio 1.32, P = 0.002). Patients with low albumin to globulin ratios had worse recurrence-free survival (P < 0.001), cancer-specific survival (P = 0.001) and overall survival (P = 0.020) in univariable and multivariable analyses after adjusting for the effect of standard preoperative prognostic factors (recurrence-free survival: hazard ratio (HR) 1.31, P = 0.001; cancer-specific survival: HR 1.31, P = 0.002 and overall survival: HR 1.18, P = 0.024).CONCLUSIONS: Lower preoperative albumin to globulin ratio is associated with locally advanced disease and worse clinical outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. As it is difficult to stage disease entity, low preoperative serum albumin to globulin ratio may help identify those most likely to benefit from intensified care, such as perioperative systemic therapy, and the extent and type of surgery.

AB - OBJECTIVE: To assess the value of preoperative albumin to globulin ratio for predicting pathologic and oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy in a large multi-institutional cohort.MATERIALS AND METHODS: Preoperative albumin to globulin ratio was assessed in a multi-institutional cohort of 2492 patients. Logistic regression analyses were performed to assess the association of the albumin to globulin ratio with pathologic features. Cox proportional hazards regression models were performed for survival endpoints.RESULTS: The optimal cut-off value was determined to be 1.4 according to a receiver operating curve analysis. Lower albumin to globulin ratios were observed in 797 patients (33.6%) compared with other patients. In a preoperative model, low preoperative albumin to globulin ratio was independently associated with nonorgan-confined diseases (odds ratio 1.32, P = 0.002). Patients with low albumin to globulin ratios had worse recurrence-free survival (P < 0.001), cancer-specific survival (P = 0.001) and overall survival (P = 0.020) in univariable and multivariable analyses after adjusting for the effect of standard preoperative prognostic factors (recurrence-free survival: hazard ratio (HR) 1.31, P = 0.001; cancer-specific survival: HR 1.31, P = 0.002 and overall survival: HR 1.18, P = 0.024).CONCLUSIONS: Lower preoperative albumin to globulin ratio is associated with locally advanced disease and worse clinical outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. As it is difficult to stage disease entity, low preoperative serum albumin to globulin ratio may help identify those most likely to benefit from intensified care, such as perioperative systemic therapy, and the extent and type of surgery.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Nephroureterectomy

KW - Preoperative Period

KW - Prognosis

KW - Proportional Hazards Models

KW - Serum Albumin/analysis

KW - Serum Globulins/analysis

KW - Urinary Bladder Neoplasms/blood

U2 - 10.1093/jjco/hyab023

DO - 10.1093/jjco/hyab023

M3 - SCORING: Journal article

C2 - 33667307

VL - 51

SP - 1149

EP - 1157

JO - JPN J CLIN ONCOL

JF - JPN J CLIN ONCOL

SN - 0368-2811

IS - 7

ER -